Portage Biotech Inc.
PRTG
$5.33
-$0.20-3.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 881.00K | 1.53M | 1.35M | 1.25M | 1.69M |
| Depreciation & Amortization | 7.00K | 8.00K | 13.00K | 15.00K | 15.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.61M | 2.85M | 3.26M | 4.04M | 5.95M |
| Operating Income | -1.61M | -2.85M | -3.26M | -4.04M | -5.95M |
| Income Before Tax | -1.36M | -1.66M | -24.91M | -48.88M | -6.07M |
| Income Tax Expenses | -- | 2.00K | 1.00K | -9.50M | -907.00K |
| Earnings from Continuing Operations | -1.36M | -1.66M | -24.91M | -39.38M | -5.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00K | 8.00K | 24.00K | 5.00K | 7.00K |
| Net Income | -1.36M | -1.66M | -24.89M | -39.37M | -5.16M |
| EBIT | -1.61M | -2.85M | -3.26M | -4.04M | -5.95M |
| EBITDA | -1.60M | -2.84M | -3.25M | -4.03M | -5.93M |
| EPS Basic | -1.26 | -1.58 | -23.75 | -37.68 | -5.80 |
| Normalized Basic EPS | -0.79 | -0.98 | 1.34 | -3.94 | -4.18 |
| EPS Diluted | -1.26 | -1.58 | -23.75 | -37.68 | -5.80 |
| Normalized Diluted EPS | -0.79 | -0.98 | 1.34 | -3.94 | -4.18 |
| Average Basic Shares Outstanding | 1.08M | 1.05M | 1.05M | 1.04M | 890.00K |
| Average Diluted Shares Outstanding | 1.08M | 1.05M | 1.05M | 1.04M | 890.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
